Quadrivalent inactivated influenza vaccine - Adimmune Corporation
Alternative Names: 4 strains seasonal flu vaccine - Adimmune; AdimFlu-S (QIS); ADIMFLU-S(QIS)- Adimmune; Flu vaccine (4 strains) - Adimmune; Tetravalent influenza vaccine - AdimmuneLatest Information Update: 08 Nov 2023
At a glance
- Originator Adimmune Corporation
- Class Anti-infectives; Influenza virus vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections
Most Recent Events
- 07 Nov 2023 Preregistration for Influenza virus infections (Prevention) in Brazil (IM)
- 12 Sep 2023 Launched for Influenza virus infections (In adolescents, In children, In the elderly, Prevention, In adults) in China (IM)
- 10 Jul 2023 Adimmune plans the commercial launch of quadrivalent inactivated influenza vaccine in mainland China (IM), in the second half of 2023